Establishing secure connection…Loading editor…Preparing document…

Healthcare Accelerator Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE ACCELERATOR AGREEMENT

This Healthcare Accelerator Agreement (the Agreement) is entered into by and between:

Effective Date: . This Agreement sets forth the terms under which the Accelerator will provide the Program services described below to the Participant.

1. TERM AND PROGRAM DESCRIPTION

Program Name: Program Start Date: Program End Date:

2. PARTICIPANT INFORMATION

Entity Type

3. FEES, EQUITY, AND PAYMENT

Admission Fee: $. Equity Consideration: of issued and outstanding equity, subject to the terms below.

4. CONFIDENTIALITY AND DATA

Each party shall keep confidential all Confidential Information disclosed by the other party and shall not disclose such information except as expressly permitted in this Agreement. Confidential Information includes non-public business information, technical data, trade secrets, and any Protected Health Information (PHI) as defined by applicable law.

If PHI will be created, received, maintained, or transmitted, the parties shall execute a Business Associate Agreement (BAA) or equivalent instrument that (i) limits use and disclosure of PHI to permitted purposes, (ii) requires appropriate safeguards and breach notification, and (iii) obligates the recipient to return or destroy PHI upon termination. Participant acknowledges that de-identified data remains subject to the de-identification methodology agreed in writing.

5. INTELLECTUAL PROPERTY

Background IP means intellectual property owned or controlled by a party prior to this Agreement. Participant retains ownership of Participant Background IP. Participant grants Accelerator a limited, non-exclusive, royalty-free license to use Participant Background IP solely to perform the Program. Accelerator will retain ownership of Accelerator-developed program materials, methodologies, and curricula. Any new inventions or improvements created jointly shall be owned as agreed in a separate written instrument.

6. REPRESENTATIONS, WARRANTIES, AND INSURANCE

Each party represents and warrants that it has the full corporate power and authority to enter into this Agreement. Participant warrants that any data shared with the Accelerator is legally obtained and that Participant has obtained all consents and authorizations required by law to permit sharing and use as contemplated herein.

7. INDEMNIFICATION; LIMITATION OF LIABILITY

Each party shall indemnify, defend and hold harmless the other party from and against any third-party claims arising from the indemnifying party's breach of this Agreement, negligence, or willful misconduct. Except for breaches of confidentiality or violations involving PHI, neither party shall be liable for indirect, incidental, consequential, punitive, or special damages. Aggregate liability shall be limited to direct damages not to exceed the total fees paid by Participant under this Agreement.

8. TERMINATION

Either party may terminate this Agreement for material breach if the breaching party fails to cure within thirty (30) days after written notice. Accelerator may suspend Participant's access to Program services upon non-payment. Termination shall not relieve Participant of obligations accrued prior to termination, including payment and confidentiality obligations.

9. NOTICES

All notices under this Agreement shall be in writing and sent to the address identified below for each party.

10. MISCELLANEOUS

Governing Law: This Agreement shall be governed by and construed in accordance with the laws of the state specified in the Parties' signature block below without regard to choice-of-law principles. Disputes shall be resolved by binding arbitration unless the parties mutually agree otherwise in writing. This Agreement constitutes the entire agreement and may only be amended in writing signed by both parties.

11. AUTHORITY TO EXECUTE

The undersigned signatories represent and warrant that they have full authority to execute this Agreement on behalf of their respective parties and to bind such parties to the terms and conditions contained herein.

Accelerator (Entity Name):

Participant (Entity Name):

By:

By:

Date:

Date:

Enter text✕

What the Healthcare Accelerator Agreement Covers

A Healthcare Accelerator Agreement is a formal contract used when an accelerator program provides services, mentorship, funding, facilities, or intellectual property guidance to healthcare startups. It sets participant eligibility, program scope, milestones, equity or fee arrangements, confidentiality and data-protection expectations, and termination conditions. The agreement clarifies obligations for clinical data handling, regulatory support, and commercialization assistance specific to healthcare ventures. It also allocates risk, assigns IP rights or licenses where appropriate, and defines post-program commitments such as reporting, follow-on investment rights, and non-compete or non-solicitation clauses.

Why a Clear Agreement Matters for Healthcare Accelerators

A well-drafted Healthcare Accelerator Agreement reduces ambiguity about services, timelines, IP ownership, and data handling, and helps protect patient data and regulatory compliance. It aligns expectations between program operators, startups, and potential investors, limiting disputes and improving probability of successful product development and commercialization.

Why a Clear Agreement Matters for Healthcare Accelerators

Who Typically Uses This Agreement

Accelerator organizations, startup founders, legal counsel, and clinical partners commonly use this agreement to formalize program participation and responsibilities.

  • Accelerator Operators — Program directors and managers who establish terms for mentorship, equity, and cohort resources.
  • Healthcare Founders — Early-stage CEOs and founders who accept support and agree to IP, milestone, and data terms.
  • Institutional Partners — Hospitals, research centers, or investors that provide funding, clinical testing, or facilities.

The agreement is also reviewed by corporate counsel and compliance officers to confirm HIPAA, research, and commercialization provisions are adequate.

Typical Signatories and Their Roles

Program Director

The program director signs for the accelerator and is responsible for delivering stated services, enforcing milestones, and allocating resources. Their signature binds the operator to confidentiality, indemnity, and program schedule obligations.

Startup CEO

The startup CEO or authorized officer signs on behalf of the participant entity, accepting equity or fee terms, IP assignment or license clauses, data sharing provisions, and representations about regulatory compliance.

Core Clauses to Include in a Professional Agreement

A Healthcare Accelerator Agreement should include clear, enforceable clauses tailored to healthcare-specific risks and commercialization steps to avoid downstream disputes and regulatory exposure.

Scope of Services

Define mentorship, lab/facility access, introductions, clinical trial support, and any paid services with measurable milestones and deliverables to avoid scope creep during the cohort.

Compensation & Equity

Specify cash fees, milestone payments, convertible notes, or equity stakes, including valuation mechanics, dilution protections, and vesting schedules tied to program milestones.

Intellectual Property

State ownership or license of pre-existing IP, assignment of newly created IP, licensing terms for platform technologies, and mechanisms for inventor credit and patent prosecution costs.

Data Protection

Include HIPAA-compliant data-handling obligations, BAA requirements where PHI may be exchanged, encryption and access controls, and breach notification timelines.

Regulatory Support

Describe any commitments to regulatory strategy, assistance with FDA submissions, shared responsibilities for clinical data, and disclaimers about regulatory outcomes.

Termination & Exit

Detail termination rights for cause or convenience, post-termination obligations for data and IP, survivability of confidentiality clauses, and dispute resolution methods.

Essential Compliance and Security Provisions

HIPAA: Include BAA when PHI is involved.
Encryption: Mandate TLS 1.2/1.3 and AES-256 for data in transit and at rest.
Access Controls: Define role-based access and MFA for sensitive systems.
Audit Trail: Require tamper-evident logs and signed record retention.
Data Retention: Specify retention and deletion schedules for participant data.
Breach Response: Set notification timelines and remediation procedures.

Step-by-Step: Completing and Executing the Agreement

Follow this sequence to prepare, review, and finalize the Healthcare Accelerator Agreement with minimal rework and clear compliance steps.

  • 01
    Prepare Draft: Gather program scope, IP stance, and data-handling terms before drafting.
  • 02
    Internal Review: Have legal and compliance review HIPAA and regulatory clauses.
  • 03
    Participant Review: Provide the draft to the startup with annotated key terms.
  • 04
    Execution: Collect signatures and retain executed copies for all parties.

Configuring an Online Signing Workflow

Set up digital execution with clear roles, authentication, and retention to ensure legal validity and auditability of signatures.

Field Configuration
Authentication Method Use email plus optional SMS OTP or KBA for higher assurance.
Signer Order Define sequential or parallel signing order per party role.
Required Attachments Require IDs or supporting exhibits at signing where needed.
Retention Settings Enable immutable audit trail and export to secure storage.

Typical Document Routing and Submission Flow

A consistent routing flow reduces signing delays and ensures each party receives the correct version and supporting records.

  • Upload Document: Program uploads final PDF with editable fields.
  • Assign Roles: Map signers, reviewers, and observers to fields.
  • Authentication: Signers authenticate via email link and optional code.
  • Finalize: System captures signatures, timestamps, and audit data.

Common Timelines and Deadlines to Track

Track these dates to meet program, regulatory, and administrative obligations tied to accelerator participation.

Application Deadline:

Date by which startups must submit applications and materials.

Program Start Date:

First official cohort day and commencement of services.

Milestone Dates:

Specific delivery or demo dates tied to funding or resources.

IP Assignment Effective Date:

Date when assignment or license obligations begin.

Record Retention Review:

Annual check to confirm storage and deletion schedules.

Primary Risks of an Incomplete or Incorrect Agreement

Data Breach Risk: Regulatory fines and reputational harm
IP Disputes: Litigation over ownership or license rights
Funding Withdrawal: Investors may rescind commitments
Contract Voidability: Ambiguity can render terms unenforceable
Compliance Violations: HIPAA or FDA noncompliance penalties
Operational Delays: Missed milestones and program setbacks

eSignature Pricing and Compliance Comparison

Compare common plan features and starting prices for platforms commonly used to execute agreements; signNow is listed first per the comparison format.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no credit card Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Available (Business Premium) Available Available Available Not available on basic plans
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes (BAA required) Yes Yes No No

Practical Tips for Drafting and Managing Agreements

Follow these practices to reduce ambiguity, improve compliance, and streamline execution of Healthcare Accelerator Agreements.

Use Defined Terms
Define capitalized terms such as 'Program', 'Participant', 'Confidential Information', and 'Clinical Data' centrally to avoid inconsistent interpretation across sections.
Limit Broad Assignments
Avoid overly broad IP assignment language affecting pre-existing technology; use limited licenses or carve-outs for background IP to protect founders.
Specify Data Uses
Be explicit about permitted analytics, secondary use, and de-identification methods to satisfy HIPAA and research partner expectations.
Document Deliverables
Attach milestone schedules, acceptance criteria, and funding triggers as exhibits to reduce disputes over whether obligations were met.

Real-World Examples from Accelerator Programs

These brief case summaries show how programs structure agreements in practice and the outcomes that can follow.

Optica Ventures — Program Execution

Optica used a standardized cohort agreement to clarify IP licensing and demo day obligations.

  • Program required quarterly milestone reports.
  • As a result, Optica streamlined onboarding, reduced negotiation time, and improved follow-on investment clarity for participating startups.

Fertility Centers of Illinois — Clinical Partnership

Fertility Centers included a tailored BAA for clinical data sharing.

  • BAA required encrypted transfer and limited use.
  • This approach allowed startups to access necessary clinical endpoints while maintaining HIPAA compliance and reducing legal review cycles.

Frequently Asked Questions and Troubleshooting

Answers to common questions about execution, eSignature validity, and compliance when using Healthcare Accelerator Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users